BioMarin Pharma (BMRN) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.64 -1.07%
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
INCOME FROM OPERATIONS: -60.09M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q3 GAAP EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $334.1 million versus the consensus estimate of $349.59 million.
GUIDANCE:
BioMarin Pharma sees FY2017 revenue of $1.29-1.32 billion, versus the consensus of $1.31 billion.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
